These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750 [TBL] [Abstract][Full Text] [Related]
12. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma. Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908 [TBL] [Abstract][Full Text] [Related]
13. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E J Clin Endocrinol Metab; 2017 Sep; 102(9):3491-3498. PubMed ID: 28911143 [TBL] [Abstract][Full Text] [Related]
14. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. Icard P; Goudet P; Charpenay C; Andreassian B; Carnaille B; Chapuis Y; Cougard P; Henry JF; Proye C World J Surg; 2001 Jul; 25(7):891-7. PubMed ID: 11572030 [TBL] [Abstract][Full Text] [Related]
15. The role of surgery in the management of recurrent adrenocortical carcinoma. Erdogan I; Deutschbein T; Jurowich C; Kroiss M; Ronchi C; Quinkler M; Waldmann J; Willenberg HS; Beuschlein F; Fottner C; Klose S; Heidemeier A; Brix D; Fenske W; Hahner S; Reibetanz J; Allolio B; Fassnacht M; J Clin Endocrinol Metab; 2013 Jan; 98(1):181-91. PubMed ID: 23150691 [TBL] [Abstract][Full Text] [Related]
16. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience. Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I BMC Urol; 2015 May; 15():43. PubMed ID: 26013141 [TBL] [Abstract][Full Text] [Related]
17. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data. Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR; Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018 [TBL] [Abstract][Full Text] [Related]
18. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease. Livhits M; Li N; Yeh MW; Harari A Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study. Souteiro P; Donato S; Costa C; Pereira CA; Simões-Pereira J; Oliveira J; Belo S; Santos AP; Cardoso H; Leite V; Carvalho D; Torres I Hormones (Athens); 2020 Jun; 19(2):197-203. PubMed ID: 31823340 [TBL] [Abstract][Full Text] [Related]
20. Surgical management and clinical prognosis of adrenocortical carcinoma. Dong D; Li H; Yan W; Ji Z; Mao Q Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]